Menu Search
Equities

4Dmedical Ltd

FDMDF:PKC

4Dmedical Ltd

Actions
  • Price (USD)0.34
  • Today's Change0.00 / 0.00%
  • Shares traded1.40k
  • 1 Year change-27.38%
  • Beta--
Data delayed at least 15 minutes, as of Nov 01 2024 13:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year 4Dmedical Ltd had net income fall 14.36% from a loss of 31.46m to a larger loss of 35.98m despite a 422.46% increase in revenues from 718.58k to 3.75m. An increase in the cost of goods sold as a percentage of sales from 4.75% to 6.31% was a component in the falling net income despite rising revenues.
Gross margin93.69%
Net profit margin-958.34%
Operating margin-982.98%
Return on assets-33.79%
Return on equity-50.54%
Return on investment-41.36%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at 4Dmedical Ltd fell by 38.97m. Cash Flow from Financing totalled 31.94m or 850.69% of revenues. In addition the company used 30.87m for operations while cash used for investing totalled 40.04m.
Cash flow per share-0.0861
Price/Cash flow per share--
Book value per share0.1728
Tangible book value per share-0.003
More ▼

Balance sheet in AUDView more

4Dmedical Ltd has a Debt to Total Capital ratio of 6.73%, a higher figure than the previous year's 5.88%.
Current ratio1.78
Quick ratio1.74
Total debt/total equity0.0722
Total debt/total capital0.0673
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.